
pmid: 18331836
We previously identified proteins that bind with high affinity to a peptide corresponding to the cytoplasmic regulatory domain (KVGFFKR) of the platelet-specific integrin subunit alpha(IIb). These included a hypothetical protein termed HSPC238, recently renamed as RING finger protein, RN181. Here, we establish the presence of RN181 in human platelets by RT-PCR, Western blotting and mass spectrometry and confirm its affinity for the platelet integrin. We demonstrate that RN181 has ubiquitin E3 ligase activity and that all other components of the ubiquitination pathway are abundant in platelets, suggesting a novel link of integrin signal transduction pathways with ubiquitin-conjugation events.
Blood Platelets, Models, Molecular, Ubiquitin-Protein Ligases, Amino Acid Motifs, Molecular Sequence Data, Ubiquitination, Platelet Glycoprotein GPIIb-IIIa Complex, Protein Structure, Tertiary, Humans, Calcium, Amino Acid Sequence, RNA, Messenger, Conserved Sequence
Blood Platelets, Models, Molecular, Ubiquitin-Protein Ligases, Amino Acid Motifs, Molecular Sequence Data, Ubiquitination, Platelet Glycoprotein GPIIb-IIIa Complex, Protein Structure, Tertiary, Humans, Calcium, Amino Acid Sequence, RNA, Messenger, Conserved Sequence
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 33 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
